Starting December 11, 2023, France’s National Agency for the Safety of Medicines (ANSM) will require a prescription to obtain eight popular cold treatments containing pseudoephedrine. Citing serious side effects such as strokes and heart attacks, the agency emphasizes the risks…
The French National Agency for the Safety of Medicines (ANSM) has announced that certain cold medications containing pseudoephedrine will only be available by prescription starting December 11. This decision follows concerns about serious side effects, including risks of heart attacks…
Alain Astier, a member of the French Academy of Medicine, advocates for the complete withdrawal of over-the-counter cold medications containing pseudoephedrine due to their potential to cause severe side effects, including strokes and heart attacks. He criticizes the efficacy of…
